Model
Edge
Alnylam Pharmaceuticals, Inc.
0001381994
Filing Type
4
Filing Date
5/11/2025
Updated
5/12/25, 2:07 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership